Concerning the other characteristics of adenomyosis mentioned above, an antifibrotic role has been shown in a variety of fibrotic diseases by targeting the cannabinoid receptor CB1 or CB2 [42–46]. This evidence concerns the gene CNR2 and adenomyosis.